Literature DB >> 14727878

In vitro assessment of alkylglycosides as permeability enhancers.

J G Eley1, P Triumalashetty.   

Abstract

series of alkylglycosides has been evaluated on human cell lines to determine its ability to open cellular tight junctions. Alkylglycosides were applied to cell monolayers; the resulting change in resistance was determined by transepithelial electrical resistance measurements. Change in resistance across cell monolayers is an indication of tight junction activation, whereas subsequent increase in resistance signifies monolayer recovery. Of the 13 alkylglycosides tested, 4 caused irreversible solubilization of cell membranes, 5 allowed a partial recovery of the monolayer after a relatively rapid reduction in resistance, and 4 induced a decrease in resistance with more complete cell recovery. Alkylglycosides allowing extensive cell recovery after removal may indicate tight junctions' activity dominance over membrane fluidity. Repeated application of alkylglycosides for 6 hours lowered resistance across cells, which returned to near-normal values after a recovery period of 48 hours. A model dye was transported across the cell monolayer only in the presence of an alkylglycoside, although recovery of cells was incomplete. Activity of the alkylglycosides was unrelated to either the carbon chain length or to the carbohydrate moiety. A direct correlation was established between the concentration of applied alkylglycoside and reduction in resistance over a constant time period. Dodecylmaltoside and octylglucoside were found to be optimal in decreasing resistance at low concentrations and allowing significant recovery of cells. Therefore these 2 alkylglycosides may be useful in facilitating drug transport across biological membranes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 14727878      PMCID: PMC2750584          DOI: 10.1208/pt020319

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  11 in total

1.  Colonic absorption of insulin: an in vitro and in vivo evaluation.

Authors:  J A Atchison; W E Grizzle; D J Pillion
Journal:  J Pharmacol Exp Ther       Date:  1989-02       Impact factor: 4.030

2.  Dodecylmaltoside-mediated nasal and ocular absorption of lyspro-insulin: independence of surfactant action from multimer dissociation.

Authors:  D J Pillion; S Hosmer; E Meezan
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

3.  Human insulin plus sodium glycocholate in a nasal spray formulation: improved bioavailability and effectiveness in normal subjects.

Authors:  A E Pontiroli; M Alberetto; E Pajetta; A Calderara; G Pozza
Journal:  Diabete Metab       Date:  1987 Jul-Aug

4.  Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.

Authors:  D Dimitrijevic; A J Shaw; A T Florence
Journal:  J Pharm Pharmacol       Date:  2000-02       Impact factor: 3.765

5.  A new approach to the oral administration of insulin and other peptide drugs.

Authors:  M Saffran; G S Kumar; C Savariar; J C Burnham; F Williams; D C Neckers
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

6.  Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility.

Authors:  E S Swenson; W B Milisen; W Curatolo
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

7.  Nasal absorption of insulin: enhancement by hydrophobic bile salts.

Authors:  G S Gordon; A C Moses; R D Silver; J S Flier; M C Carey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.

Authors:  A C Moses; G S Gordon; M C Carey; J S Flier
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

9.  Systemic absorption of insulin delivered topically to the rat eye.

Authors:  D J Pillion; J D Bartlett; E Meezan; M Yang; R J Crain; W E Grizzle
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-11       Impact factor: 4.799

10.  Fracture faces of zonulae occludentes from "tight" and "leaky" epithelia.

Authors:  P Claude; D A Goodenough
Journal:  J Cell Biol       Date:  1973-08       Impact factor: 10.539

View more
  4 in total

1.  A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.

Authors:  Sagar Munjal; Elimor Brand-Schieber; Kent Allenby; Egilius L H Spierings; Roger K Cady; Alan M Rapoport
Journal:  J Headache Pain       Date:  2017-03-01       Impact factor: 7.277

2.  Strengthening peptide-based drug activity with novel glyconanoparticle.

Authors:  Jordan D Lewicky; Alexandrine L Martel; Nya L Fraleigh; Amanda Boraman; Thi M-D Nguyen; Peter W Schiller; Tze Chieh Shiao; René Roy; Hoang-Thanh Le
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

3.  Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn's Disease.

Authors:  Adeline Sivignon; Xibo Yan; Dimitri Alvarez Dorta; Richard Bonnet; Julie Bouckaert; Etienne Fleury; Julien Bernard; Sébastien G Gouin; Arlette Darfeuille-Michaud; Nicolas Barnich
Journal:  mBio       Date:  2015-11-17       Impact factor: 7.867

4.  Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes.

Authors:  Catarina Dias; João P Pais; Rafael Nunes; Maria-Teresa Blázquez-Sánchez; Joaquim T Marquês; Andreia F Almeida; Patrícia Serra; Nuno M Xavier; Diogo Vila-Viçosa; Miguel Machuqueiro; Ana S Viana; Alice Martins; Maria S Santos; Ana Pelerito; Ricardo Dias; Rogério Tenreiro; Maria C Oliveira; Marialessandra Contino; Nicola A Colabufo; Rodrigo F M de Almeida; Amélia P Rauter
Journal:  Nat Commun       Date:  2018-11-19       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.